Triptorelin Peptide Vial

Triptorelin (GnRH) Peptide Vial 2mg New Zealand

Triptorelin is a GnRH agonist (gonadotropin releasing hormone) that inhibits the synthesis of estrogen in women and testosterone in men. It’s used for advanced prostate cancer treatment.  Your testosterone level will increase for the first few weeks of taking this medication, but it will eventually decrease. This kind of response is normal and may result in worsening or new symptoms.

How Triptorelin works?

Research has shown this peptide can treat premature puberty, advanced prostate cancer, and other disorders. Furthermore, women undergoing controlled ovarian hyperstimulation may only use a Canadian triptorelin brand for assisted reproductive technologies.

Triptorelin is a GnRH agonist analogue. GnRH controls LH and FSH secretion (FSH). Gonadotropins like LH and FSH cause the gonads (male testes and female ovaries) to release hormones. The peptide initially increases FSH, LH, testosterone, and estradiol, but a negative feedback loop leads to a prolonged decline in FSH and LH and a considerable decrease in ovarian and testicular steroidogenesis 2 to 4 weeks after initiation. Studies have demonstrated that the peptide lowers testosterone in men, reducing cancer cell proliferation and alleviating urinary problems. In addition, Triptorelin reduces premature LH surges in controlled ovarian hyperstimulation patients using assisted reproductive technologies (ART).

Gonadotropin-releasing hormone agonists include triptorelin.

Benefits of Triptorelin New Zealand

• The peptide reduces the amount of testosterone produced by the body, which helps stop or slow cancer cell growth.
• It also helps alleviate symptoms like difficult or painful urination.
• The peptide can also be used for treating CPP (central precocious puberty), a condition that causes children to enter puberty prematurely that results in the development of sexual features in kids two years and older. This condition also causes bones to grow at a faster rate.